Group 1 - In the first 11 months of the year, 626 out of 650 comparable QDII funds saw an increase in net value, representing 96.3% of the total [1] - The innovative pharmaceutical sector has rebounded, leading to significant gains for funds heavily invested in this area, with the top-performing fund, Huatai Fuhong Hong Kong Advantage Selection Mixed A/C, achieving a return of 141.57% [1] - The fund's investment strategy focuses on innovative drugs with global competitiveness and high barriers in the medical equipment sector [1] Group 2 - Nine QDII funds recorded gains exceeding 87% in the first 11 months, with four funds from E Fund Management achieving over 92% returns [2] - The top holdings of these funds include companies like Fuhong Hanlin, Xinda Biopharmaceutical, and Keren Biotech [2] - Other high-performing funds include Chuangjin Hexin Global Pharmaceutical Biotechnology Stock Initiation A and C, and GF CSI Hong Kong Innovative Medicine ETF, with returns of 100.32% and 99.68% respectively [2] Group 3 - The Industrial Bank New Economy Mixed Dollar fund, managed by Zhao Bei, has top holdings including Xinda Biopharmaceutical and Jinfang Pharmaceutical [3] - Funds focused on oil and gas, as well as real estate, have underperformed, particularly those tracking the FTSE Saudi Arabia Index [3] Group 4 - The top 10 QDII funds by performance in the first 11 months include Huatai Fuhong Hong Kong Advantage Selection Mixed A, with a return of 141.57%, and E Fund Global Pharmaceutical Industry Mixed C, with a return of 95.67% [4] - The performance of these funds highlights the strong returns in the pharmaceutical sector compared to other sectors like oil and real estate [4]

Group 1 - The core announcement is regarding the third dividend distribution for the year 2025 by E Fund Management Co., Ltd. for the E Fund Shen High-Speed Highway Closed-End Infrastructure Securities Investment Fund [1] - The dividend distribution base date is set for September 9, with a detailed dividend plan indicating a distribution of 2.24 yuan per 10 shares for the E Fund Shen High-Speed REIT (code: 508033) [1] - The beneficiaries of this dividend are all fund holders registered on the equity registration date of December 9, with cash dividends to be distributed on December 11 [1] Group 2 - The fund will distribute earnings through cash dividends, and reinvestment of dividends is not supported [1] - According to relevant laws and regulations, the fund's earnings distributed to investors are currently exempt from income tax [1] - There will be no dividend handling fees charged for this distribution [1]

Core Viewpoint - The performance of ordinary stock funds in China has been predominantly positive in 2023, with 97% of comparable funds reporting gains, largely driven by the semiconductor sector's strong performance. Group 1: Fund Performance - As of November 30, 2023, out of 970 comparable ordinary stock funds, 941 funds achieved positive performance, representing a 97% success rate, while only 29 funds experienced declines [1] - The top-performing funds include E Fund Strategic Emerging Industries Stock A and C, both of which saw gains exceeding 90%, primarily due to the semiconductor sector's robust growth [1] - E Fund Information Industry Select Stock A ranked third with a 89.71% increase, benefiting from similar sector trends [1] Group 2: Fund Managers and Holdings - The fund manager of E Fund Strategic Emerging Industries, Ouyang Liangqi, has a background as an industry researcher and has been managing the fund since 2023 [1] - E Fund Information Industry Select Stock A's manager, Zheng Xi, has 13 years of management experience and oversees a portfolio heavily invested in semiconductor stocks [2] - The top holdings of these funds include major companies like Tencent, Alibaba, and various semiconductor firms, indicating a concentrated investment strategy in high-growth sectors [1][2] Group 3: Underperforming Funds - Only 14 ordinary stock funds reported declines exceeding 5% in the same period, with the largest losses seen in Taikang Medical Health Stock A and C, which fell by -10.56% and -10.14% respectively [3] - The underperforming funds primarily focused on healthcare and biopharmaceutical sectors, which have not matched the growth seen in technology and semiconductor sectors [3] - The cumulative returns of some underperforming funds, such as the Shenwan Lixin Medical Pioneer Stock, showed significant losses of up to 51.99% [3]

Quantitative Models and Construction Methods Index Enhancement Strategies - **Model Name**: Index Enhancement Strategy for CSI 300, CSI 500, CSI 1000, and CSI 2000 - **Model Construction Idea**: The strategy is based on a multi-factor stock selection model, leveraging an equity factor library to identify effective factors within the constituent stocks of the respective indices[77] - **Model Construction Process**: - **Factor Selection**: Hundreds of factors from the equity factor library are screened for effectiveness within the constituent stocks of CSI 300, CSI 500, CSI 1000, and CSI 2000 indices[77] - **Portfolio Optimization**: - For CSI 300: Strict sector and market capitalization neutrality, individual stock weight capped at 8%, and weight deviation capped at 3%[77] - For CSI 500: Strict sector and market capitalization neutrality, individual stock weight capped at 1%, and weight deviation capped at 1%[77] - For CSI 1000 and CSI 2000: Market capitalization deviation capped at 0.5 standard deviations, sector deviation capped at 2.5%, individual stock weight capped at 1% for CSI 1000 and 0.5% for CSI 2000[77] - **Rebalancing**: Weekly tracking of the performance of the index enhancement strategy within the constituent stocks[77] Model Evaluation - **Evaluation**: The strategy effectively utilizes a multi-factor approach to enhance index performance while maintaining sector and market capitalization neutrality. However, the strategy's performance is subject to transaction costs and historical data limitations[77][83] --- Model Backtesting Results CSI 300 Index Enhancement Strategy - **Weekly Return**: 1.53% (Index Return: 1.64%, Excess Return: -0.12%)[78] - **Monthly Return**: -3.31% (Index Return: -2.46%, Excess Return: -0.85%)[78] - **Year-to-Date Return**: 21.83% (Index Return: 15.04%, Excess Return: 6.8%)[78] - **Maximum Drawdown of Excess Return**: -3.15%[78] CSI 500 Index Enhancement Strategy - **Weekly Return**: 2.97% (Index Return: 3.14%, Excess Return: -0.17%)[78] - **Monthly Return**: -4.54% (Index Return: -4.08%, Excess Return: -0.46%)[78] - **Year-to-Date Return**: 23.41% (Index Return: 22.81%, Excess Return: 0.61%)[78] - **Maximum Drawdown of Excess Return**: -4.77%[78] CSI 1000 Index Enhancement Strategy - **Weekly Return**: 3.77% (Index Return: 3.77%, Excess Return: 0%)[83] - **Monthly Return**: -2.59% (Index Return: -2.3%, Excess Return: -0.29%)[83] - **Year-to-Date Return**: 35.59% (Index Return: 23.1%, Excess Return: 12.49%)[83] - **Maximum Drawdown of Excess Return**: -5.59%[83] CSI 2000 Index Enhancement Strategy - **Weekly Return**: 4.38% (Index Return: 4.99%, Excess Return: -0.61%)[83] - **Monthly Return**: -0.03% (Index Return: -0.4%, Excess Return: 0.37%)[83] - **Year-to-Date Return**: 59.74% (Index Return: 31.65%, Excess Return: 28.08%)[83] - **Maximum Drawdown of Excess Return**: -5.23%[83] --- Quantitative Factors and Construction Methods Single Factors - **Factor Name**: Analyst Forecast ROE-FY3 - **Construction Idea**: Measures the expected return on equity (ROE) for the next three fiscal years as forecasted by analysts[33] - **Construction Process**: Derived from analyst consensus estimates for ROE over the next three fiscal years[33] - **Evaluation**: Demonstrates strong predictive power for stock selection, particularly in CSI 300 and CSI 2000 stock pools[33][36] - **Factor Name**: Standardized Unexpected Quarterly ROE with Drift - **Construction Idea**: Captures the deviation of actual quarterly ROE from expectations, adjusted for drift[35] - **Construction Process**: - Calculate the unexpected component of quarterly ROE - Standardize the values and adjust for drift to account for temporal effects[35] - **Evaluation**: Effective in identifying outperforming stocks, particularly in CSI 1000 and CSI 2000 stock pools[35][36] - **Factor Name**: One-Month Price Change - **Construction Idea**: Reflects short-term momentum by measuring the percentage change in stock price over the past month[36] - **Construction Process**: Calculate the percentage change in stock price over the last 30 days[36] - **Evaluation**: Demonstrates strong performance in CSI 2000 and CSI 1000 stock pools, indicating momentum effects[36] Factor Neutralization - **Neutralization Process**: - Apply absolute median method for outlier removal - Perform Z-score standardization - Conduct cross-sectional regression using log market capitalization and industry dummy variables as independent variables, with the factor as the dependent variable - Use the residuals as the neutralized factor values[32] --- Factor Backtesting Results CSI 300 Stock Pool - **Top Factors (Year-to-Date Excess Return)**: - Single-Quarter Revenue Growth Rate: 25.24%[33] - Single-Quarter ROE: 22.28%[33] - Single-Quarter ROA Change: 22.21%[33] CSI 500 Stock Pool - **Top Factors (Year-to-Date Excess Return)**: - Analyst Forecast Net Profit Growth Rate FY3: 14.53%[34] - Analyst Forecast Revenue Growth Rate FY3: 13.69%[34] - Analyst Forecast Revenue FY3 120-Day Change: 12.81%[34] CSI 1000 Stock Pool - **Top Factors (Year-to-Date Excess Return)**: - Standardized Unexpected Quarterly ROE with Drift: 19.18%[35] - Analyst Forecast ROE-FY3 120-Day Change: 18.4%[35] - Standardized Unexpected Quarterly Net Profit with Drift: 18.34%[35] CSI 2000 Stock Pool - **Top Factors (Year-to-Date Excess Return)**: - 90-Day Report Upward Revision Ratio: 25.01%[36] - Standardized Unexpected Quarterly Net Profit with Drift: 24.46%[36] - 5-Minute Volume Skewness: 23.74%[36] CSI All-Share Stock Pool - **Top Factors (Year-to-Date Excess Return)**: - Analyst Forecast ROE-FY3 120-Day Change: 23.52%[37] - Single-Quarter Revenue Growth Rate: 20.47%[37] - Analyst Forecast Revenue Growth Rate FY3: 19.35%[37]

登录新浪财经APP 搜索【信披】查看更多考评等级 基金管理人：易方达基金管理有限公司 基金托管人：中国工商银行股份有限公司 2.本基金为交易型开放式、股票型证券投资基金、指数基金。 3.本基金的管理人为易方达基金管理有限公司（以下简称"本公司"），托管人为中国工商银行股份有限 公司，本基金登记结算机构为中国证券登记结算有限责任公司。 4.本基金将自2025年12月11日至2025年12月19日进行发售。本基金的投资人可选择网上现金认购和网下 现金认购2种方式（本基金暂不开通网下股票认购），其中网下现金认购的日期为2025年12月11日至 2025年12月19日，网上现金认购的日期为2025年12月11日至2025年12月19日。如深圳证券交易所对网上 现金认购时间作出调整，本公司将作出相应调整并及时公告。基金管理人根据认购的情况可适当调整募 集时间，并及时公告，但最长不超过法定募集期限。 5.网上现金认购是指投资人通过具有基金销售业务资格的深圳证券交易所会员用深圳证券交易所网上系 统以现金进行的认购；网下现金认购是指投资人通过基金管理人及其指定的发售代理机构以现金进行的 认购。 6.投资者认购本基金时需具有深 ...

平安惠韵纯债A/C成立于2022年6月9日，截至2025年12月3日，其今年来收益率为0.95%、0.90%， 成立来收益率为12.25%、11.03%，累计净值为1.1201元、1.1102元。 | 基金名称 | 平安惠韵纯债债券型证券投资基金 | | --- | --- | | 基金简称 | 平安惠韵纯债 | | 基金主代码 | 014710 | | 基金管理人名称 | 平安基金管理有限公司 | | 公告依据 | 《公开募集证券投资基金信息披露管理办 | | | 法》 | | 基金经理变更类型 | 解聘基金经理 | | 新任基金经理姓名 | | | 共同管理本基金的其他基金经理姓名 | 李晓天 | | 离任基金经理姓名 | 苏宁 | 中国经济网北京12月4日讯 今日，平安基金公告，苏宁离任平安惠韵纯债，李晓天管理。 苏宁曾先后担任易方达基金管理有限公司固定收益交易员、固定收益研究员兼基金经理助理。曾任 易方达基金管理有限公司易方达稳健收益债券型证券投资基金基金经理助理、易方达信用债债券型证券 投资基金基金经理助理、易方达裕惠回报定期开放式混合型发起式证券投资基金基金经理助理。2019年 6月加入平安基金管 ...

中国经济网北京12月3日讯今日，易方达基金公告，易方达中小企业100指数(LOF)增聘刘越洲。 易方达中小企业100指数(LOF)A/C成立于2012年9月20日和2021年7月21日，截至2025年12月2日，其今 年来收益率为25.67%、25.33%，成立来收益率为85.97%、-12.62%，累计净值为1.4314元、1.4131元。 | 基金名称 | 易方达中小企业 100指数证券投资基金(LOF) | | --- | --- | | 基金简称 | 易方达中小企业 100 指数(LOF) | | 基金主代码 | 161118 | | 基金管理人名称 | 易方达基金管理有限公司 | | 公告依据 | 《公开募集证券投资基金信息披露管理办法》 《基金管理公司投资管理人员管理指导意见》 《易方达中小企业 100指数证券投资基金(LOF) | | | 基金合同》 | | 基金经理变更类型 | 增聘基金经理 | | 新任基金经理姓名 | 刘越洲 | | 共同管理本基金的其他基金经理姓名 | 刘树荣 | 刘越洲2020年11月起在易方达基金管理有限公司任职，现任基金经理、基金经理助理、研究员。 ...

中国经济网北京12月3日讯今日，易方达基金公告，易方达上证中盘ETF、易方达上证中盘ETF联接增 聘刘砚芳。 刘砚芳2021年7月起在易方达基金管理有限公司任职，现任基金经理、基金经理助理、研究员。 易方达上证中盘ETF成立于2010年3月29日，截至2025年12月2日，其今年来收益率为17.09%，成立来收 益率为140.67%，累计净值为2.4140元。 易方达上证中盘ETF联接A/C成立于2010年3月11日和2017年6月2日，截至2025年12月2日，其今年来收 益率为16.07%、15.79%，成立来收益率为132.48%、89.59%，累计净值为2.3248元、2.3498元。 | 基金名称 | 易方达上证中盘交易型开放式指数证券投资基金 | | --- | --- | | 基金同称 | 易方达上证中盘 ETF | | 基金主代码 | 510130 | | 基金管理人名称 | 易方达基金管理有限公司 | | 公告依据 | 《公开募集证券投资基金信息披露管理办法》 《基金管理公司投资管理人员管理指导意见》 | | | 《易方达上证中盘交易型开放式指数证券投资基 | | | 金基金合同》 | | ...

Core Insights - E Fund announced the appointment of Nie Qiwen as a new fund manager for multiple ETFs, including the E Fund CSI Internet of Things Theme ETF and the E Fund CSI Modern Agriculture Theme ETF [1][2][3][4] Fund Performance Summary - E Fund CSI Internet of Things Theme ETF, established on October 13, 2021, has a year-to-date return of 39.03% and a cumulative return since inception of 19.91%, with a net asset value of 1.1991 yuan as of December 2, 2025 [1] - E Fund CSI Internet of Things Theme ETF Link Fund A/C, launched on September 26, 2023, has year-to-date returns of 36.77% and 36.40%, and cumulative returns since inception of 55.32% and 54.27%, with net asset values of 1.5532 yuan and 1.5427 yuan respectively [1] - E Fund CSI State-Owned Enterprise Reform Index (LOF) A/C, established on June 15, 2015, and July 19, 2021, has year-to-date returns of 8.62% and 8.37%, and cumulative returns since inception of -3.14% and -4.31%, with net asset values of 0.9272 yuan and 1.4730 yuan respectively [1] - E Fund CSI Modern Agriculture Theme ETF, launched on December 2, 2021, has a year-to-date return of 10.49% and a cumulative return since inception of -20.45%, with a net asset value of 0.7955 yuan [2]

本次分红对象为权益登记日在易方达基金管理有限公司登记在册的本基金全体持有人。，权益登记日为 12月4日，现金红利发放日为12月5日。选择红利再投资方式的投资者红利再投资所得的基金份额将按 2025年12月4日的基金份额净值计算确定，本公司将于红利发放日对红利再投资的基金份额进行确认并 通知各销售机构，本次红利再投资所得份额的持有期限自红利发放日开始计算。2025年12月8日起投资 者可以查询、赎回。权益登记日之前（不含权益登记日）办理了转托管转出尚未办理转托管转入的基金 份额，其分红方式按照红利再投资处理。根据相关法律法规规定，基金向投资者分配的基金收益，暂不 征收所得税。本基金本次分红免收分红手续费；选择红利再投资方式的投资者其红利再投资所得的基金 份额免收申购费用。 证券之星消息，12月3日发布《易方达红利混合型证券投资基金分红公告》。本次分红为2025年度的第2 次分红。公告显示，本次分红的收益分配基准日为11月11日，详细分红方案如下： | 分级基金筒称 | 代码 | 基准日基金净值 | | 分红方案 | | | --- | --- | --- | --- | --- | --- | | | | (元 ...